Related Experiment Videos

Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia

I Hughes1, M E Jenney, R W Newton

  • 1Department of Neurology, Royal Manchester Children's Hospital.

Insights

Measles encephalitis in children with acute lymphoblastic leukemia is difficult to diagnose. Increasing measles herd immunity through vaccination is crucial for preventing this severe complication in immunocompromised children.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Onco-immunology

Background:

  • Measles encephalitis poses a significant risk to immunocompromised children, particularly those undergoing chemotherapy for acute lymphoblastic leukemia (ALL).
  • Understanding the diagnostic challenges and effective prevention strategies is critical for this vulnerable population.

Observation:

  • Five cases of measles encephalitis in children with ALL were identified between 1971 and 1989.
  • A review of these and prior cases revealed no pathognomonic features in clinical presentation, history, EEG, or CT scans.
  • Detection of measles virus antigen or specific antibodies was inconsistent, complicating diagnosis.

Findings:

  • Diagnosing measles encephalitis in immunosuppressed children is challenging due to the lack of specific clinical or diagnostic markers.
  • Difficulties in brain biopsy targeting also hinder early etiological diagnosis.
  • Measles virus detection in various samples proved unreliable in many instances.

Implications:

  • Enhanced herd immunity via widespread measles vaccination is the primary preventive measure against measles encephalitis in immunocompromised children.
  • Measles encephalitis should be considered in the differential diagnosis of encephalopathy in immunocompromised pediatric patients.
  • Further research is needed to evaluate the potential benefits of early antiviral agent administration.

Related Concept Videos